Evidence map›Paper›PMID 37225946›Full record

Observational studyEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2023

Outcomes of medicaid patients undergoing TJA with previous positive urine toxicology screens.

Michael Moore, Irina Shendrik, Mackenzie A Roof, Chelsea Sue Sicat, Morteza Meftah, Ran Schwarzkopf, Joshua C Rozell

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michael MooreNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA. Michael.Moore@nyulangone.org.ORCID http://orcid.org/0000-0003-2748-9988
Irina ShendrikNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA.
Mackenzie A RoofNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA.
Chelsea Sue SicatNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA.
Morteza MeftahNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA.
Ran SchwarzkopfNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA.
Joshua C RozellNYU Langone Orthopedic Hospital, NYU Langone Health, 334 East 26Th Street, New York, NY, 10003, USA.
NYU Langone Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrevious studies have demonstrated that patients with positive preoperative urine toxicology (utox) screens prior to total joint arthroplasty (TJA) have higher readmission rates, greater complication rates, and longer hospital stays compared to patients with negative screens. The aim of this study was to investigate the effect of postponing surgery for patients with positive preoperative utox in the Medicaid population.

methodsThis retrospective, observational study reviewed the Medicaid ambulatory database at a large, academic orthopedic specialty hospital for patients with a utox screen prior to TJA from 2012 to 2020. Patients were categorized into three groups: (1) controls with negative preoperative utox or a utox consistent with prescription medications (Utox-) with TJA completed as scheduled; (2) positive preoperative utox with TJA rescheduled and surgery completed on a later date (R-utox+); (3) positive preoperative utox inconsistent with prescription medications with TJA completed as scheduled (S-utox+). Primary outcomes included mortality, 90-day readmission rate, complication rate, and length of stay.

resultsOf the 300 records reviewed, 185 did not meet inclusion criteria. The remaining 115 patients included 80 (69.6%) Utox-, 5 (6.3%) R-utox+, and 30 (37.5%) S-utox+. Mean follow-up time was 49.6 months. Hospital stays trended longer in the Utox- group (3.7 ± 2.0 days vs. 3.1 ± 1.6 S-utox+ vs.2.5 ± 0.4 R-utox+, p = 0.20). Compared to the R-utox+group, the S-utox+ group trended toward lower home discharge rates (p = 0.20), higher in-hospital complication rates (p = 0.85), and more all-cause 90-day emergency department visits (p = 0.57). There were no differences in postoperative opioid utilization between groups (p = 0.319). Duration of postoperative narcotic use trended toward being longer in the Utox- patients (820.7 ± 1073.8 days vs. 684.6 ± 1491.8 S-utox+ vs. 585.1 ± 948.3 R-utox+, p = 0.585). Surgical time (p = 0.045) and revision rates (p = 0.72) trended toward being higher in the S-utox+ group.

conclusionsMedicaid patients with positive preoperative utox who had surgeries postponed trended towards shorter hospital stays and greater home discharge rates. Larger studies should be conducted to analyze the implications of a positive preoperative utox on risk profiles and outcomes following TJA in the Medicaid population. Study design Retrospective cohort study.

Indexed as

Arthroplasty, Replacement, HipArthroplasty, Replacement, KneeHumansLength of StayMedicaidRetrospective StudiesUnited StatesMedicaidOpioidsTotal hip arthroplastyTotal joint arthroplastyTotal knee arthroplastyUrine toxicology

Identifiers

PMID37225946
OpenAlexW4377990011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.